113 related articles for article (PubMed ID: 32016002)
1. Is there value of tumor stromal infiltrating lymphocytes for response assessment to chemoradiation in esophageal squamous cell carcinoma?
Wang X; Jing W; Lin SH
Ann Transl Med; 2019 Dec; 7(Suppl 8):S283. PubMed ID: 32016002
[No Abstract] [Full Text] [Related]
2. A high number of stromal tumor-infiltrating lymphocytes is a favorable independent prognostic factor in M0 (stages I-III) esophageal squamous cell carcinoma.
Li J; Tang Y; Huang L; Yu Q; Hu G; Zou Y; Yuan X
Dis Esophagus; 2017 Jan; 30(1):1-7. PubMed ID: 27868286
[TBL] [Abstract][Full Text] [Related]
3. Tumor-Infiltrating CD4+ Lymphocytes Predict a Favorable Survival in Patients with Operable Esophageal Squamous Cell Carcinoma.
Chen K; Zhu Z; Zhang N; Cheng G; Zhang F; Jin J; Wu J; Ying L; Mao W; Su D
Med Sci Monit; 2017 Sep; 23():4619-4632. PubMed ID: 28949934
[TBL] [Abstract][Full Text] [Related]
4. Tumor Remission and Tumor-Infiltrating Lymphocytes During Chemoradiation Therapy: Predictive and Prognostic Markers in Locally Advanced Esophageal Squamous Cell Carcinoma.
Qian D; Wang Y; Zhao G; Cao F; Er P; Chen X; Cheng J; Zhang W; Li X; Zhang B; Guan Y; Zhou D; Wang J; Jiang H; Yu Z; Yuan Z; Wang P; Pang Q
Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):319-328. PubMed ID: 31228553
[TBL] [Abstract][Full Text] [Related]
5. Percentage of tumor-infiltrating lymphocytes after chemoradiation therapy for locally advanced esophageal squamous cell carcinoma: a biomarker for pathological response rates and cancer-specific survival?
Groth SS; Burt BM
Ann Transl Med; 2019 Dec; 7(Suppl 8):S310. PubMed ID: 32016029
[No Abstract] [Full Text] [Related]
6. The prognostic value of circumferential resection margin in esophageal squamous cell carcinoma after concurrent chemoradiation therapy and surgery.
Liu CY; Wang BY; Lee MY; Tsai YC; Liu CC; Shih CH
J Chin Med Assoc; 2013 Oct; 76(10):570-5. PubMed ID: 23938149
[TBL] [Abstract][Full Text] [Related]
7. Should adenosquamous esophageal cancer be treated like adenocarcinoma or squamous cell carcinoma?
Gamboa AC; Meyer BI; Switchenko JM; Rupji M; Lee RM; Turgeon MK; Russell MC; Cardona K; Kooby DA; Maithel SK; Shah MM
J Surg Oncol; 2020 Sep; 122(3):412-421. PubMed ID: 32462769
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of Tumor-Infiltrating Lymphocytes Differs Depending on Lymphocyte Subsets in Esophageal Squamous Cell Carcinoma: An Updated Meta-Analysis.
Hao J; Li M; Zhang T; Yu H; Liu Y; Xue Y; An R; Wang S
Front Oncol; 2020; 10():614. PubMed ID: 32411602
[No Abstract] [Full Text] [Related]
9. Prognostic significance of tumor-infiltrating immune cells and PD-L1 expression in esophageal squamous cell carcinoma.
Jiang Y; Lo AWI; Wong A; Chen W; Wang Y; Lin L; Xu J
Oncotarget; 2017 May; 8(18):30175-30189. PubMed ID: 28404915
[TBL] [Abstract][Full Text] [Related]
10. CMISG1701: a multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamous cell carcinoma (cT
Tang H; Tan L; Shen Y; Wang H; Lin M; Feng M; Xu S; Guo W; Qian C; Liu T; Zeng Z; Hou Y; Yu Z; Jiang H; Li Z; Chen C; Lian C; Du M; Li H; Xie D; Yin J; Zhao N; Wang Q
BMC Cancer; 2017 Jun; 17(1):450. PubMed ID: 28659128
[TBL] [Abstract][Full Text] [Related]
11. PD-L1 expression on stromal tumor-infiltrating lymphocytes is a favorable prognostic factor in ovarian serous carcinoma.
Kim KH; Choi KU; Kim A; Lee SJ; Lee JH; Suh DS; Kwon BS; Hwang C
J Ovarian Res; 2019 Jun; 12(1):56. PubMed ID: 31208449
[TBL] [Abstract][Full Text] [Related]
12. Tumour infiltrating lymphocytes correlate with improved survival in patients with esophageal squamous cell carcinoma.
Jiang D; Liu Y; Wang H; Wang H; Song Q; Sujie A; Huang J; Xu Y; Zeng H; Tan L; Hou Y; Xu C
Sci Rep; 2017 Mar; 7():44823. PubMed ID: 28322245
[TBL] [Abstract][Full Text] [Related]
13. [18F]-Fluorodeoxyglucose-positron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemoradiation in esophageal cancer.
Vallböhmer D; Hölscher AH; Dietlein M; Bollschweiler E; Baldus SE; Mönig SP; Metzger R; Schicha H; Schmidt M
Ann Surg; 2009 Dec; 250(6):888-94. PubMed ID: 19953708
[TBL] [Abstract][Full Text] [Related]
14. Isolation of T cell receptor specifically reactive with autologous tumour cells from tumour-infiltrating lymphocytes and construction of T cell receptor engineered T cells for esophageal squamous cell carcinoma.
Tan Q; Zhang C; Yang W; Liu Y; Heyilimu P; Feng D; Xing L; Ke Y; Lu Z
J Immunother Cancer; 2019 Aug; 7(1):232. PubMed ID: 31462302
[TBL] [Abstract][Full Text] [Related]
15. ERCC1 expression and tumor regression predict survival in esophageal squamous cell carcinoma patients receiving combined trimodality therapy.
Ge H; Lu Y; Chen Y; Zheng X; Wang W; Yu J
Pathol Res Pract; 2014 Oct; 210(10):656-61. PubMed ID: 25042384
[TBL] [Abstract][Full Text] [Related]
16. The prognostic significance of tumour infiltrating lymphocytes in oral squamous cell carcinoma.
Książek M; Lewandowski B; Brodowski R; Pakla P; Kawalec-Książek M; Fudali L; Ryś J
Pol J Pathol; 2019; 70(4):277-285. PubMed ID: 32146797
[TBL] [Abstract][Full Text] [Related]
17. Significant involvement of herpesvirus entry mediator in human esophageal squamous cell carcinoma.
Migita K; Sho M; Shimada K; Yasuda S; Yamato I; Takayama T; Matsumoto S; Wakatsuki K; Hotta K; Tanaka T; Ito M; Konishi N; Nakajima Y
Cancer; 2014 Mar; 120(6):808-17. PubMed ID: 24249528
[TBL] [Abstract][Full Text] [Related]
18. PD-L1 expression and its clinicopathological correlation in advanced esophageal squamous cell carcinoma in a Chinese population.
Rong L; Liu Y; Hui Z; Zhao Z; Zhang Y; Wang B; Yuan Y; Li W; Guo L; Ying J; Song Y; Wang L; Zhou Z; Xue L; Lu N
Diagn Pathol; 2019 Jan; 14(1):6. PubMed ID: 30684971
[TBL] [Abstract][Full Text] [Related]
19. Impact on Radiological and Pathological Response with Neoadjuvant Chemoradiation and Its Effect on Survival in Squamous Cell Carcinoma of Thoracic Esophagus.
Dewan A; Sharma SK; Dewan AK; Khurana R; Gupta M; Pahuja A; Srivastava H; Sinha R
J Gastrointest Cancer; 2017 Mar; 48(1):42-49. PubMed ID: 27604122
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant versus adjuvant chemoradiation for stage II-III esophageal squamous cell carcinoma: a single institution experience.
Chen Y; Hao D; Wu X; Xing W; Yang Y; He C; Wang W; Liu J; Wang J
Dis Esophagus; 2017 Jul; 30(7):1-7. PubMed ID: 28475725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
